Adam J. Olm-Shipman

In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells

Benjamin J. Frisch, Rebecca L. Porter, Benjamin J. Gigliotti et al. · Blood · 2009 · 84 citations · Full text

Life Sciences, Cell Biology, Hematology +16

Exome sequencing reveals a thrombopoietin ligand mutation in a Micronesian family with autosomal recessive aplastic anemia

Majed Dasouki, Syed K. Rafi, Adam J. Olm-Shipman et al. · Blood · 2013 · 67 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

SPECC1L deficiency results in increased adherens junction stability and reduced cranial neural crest cell delamination

Nathan R. Wilson, Adam J. Olm-Shipman, Diana S. Acevedo et al. · Scientific Reports · 2016 · 52 citations · Full text

Life Sciences, Developmental Biology, Genetics +16

A Cell-Based Phenotypic Assay to Identify Cardioprotective Agents

Stephanie Guo, Adam J. Olm-Shipman, Andrew M. Walters et al. · Circulation Research · 2012 · 27 citations · Full text

Life Sciences, Pharmacology, Physiology +13

Anti-epileptic drug topiramate upregulates TGFβ1 and SOX9 expression in primary embryonic palatal mesenchyme cells: Implications for teratogenicity

Syed K. Rafi, Jeremy P. Goering, Adam J. Olm-Shipman et al. · PLoS ONE · 2021 · 12 citations · Full text

Life Sciences, Molecular Medicine, Pharmacology +10